Kimalyn A. Dumas, CRNP

Kimalyn Dumas practices at First Physicians Group in Nokomis, Florida.

Kimalyn Dumas' NPI, 1174505101, was assigned on November 16, 2005. Kimalyn Dumas holds Florida license ARNP9422997.

Kimalyn Dumas' primary practice is First Physicians Group, at 200 Healthcare Way, Nokomis, FL 34275 in Sarasota County. The practice phone is (941) 917-8720.

Kimalyn Dumas' primary practice is First Physicians Group in Nokomis, Florida. Kimalyn Dumas is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is First Physicians Group of Sarasota. Dmand AI also links Kimalyn Dumas to 2 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kimalyn Dumas practices, 5 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Kimalyn Dumas' primary specialty in the NPI Registry, under taxonomy code 363L00000X. Dmand AI has Kimalyn Dumas' licenses on file in 2 states: Florida and Alabama.

Dmand AI lists acute mini-stroke (TIA), acute sinusitis, acute skin infection, alcohol use disorders, alzheimer's disease, ankle or foot injury, anxiety and arthritis among the conditions Kimalyn Dumas treats.

CMS data shows 7,153 Medicare services from Kimalyn Dumas across 13 procedure codes in 2024, for 950 Medicare patients. Medicare paid $203,652 for them. Every service was in an office.

CMS counts 950 Medicare patients who saw Kimalyn Dumas in 2024. The largest group is 75 to 84, with 345 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Kimalyn Dumas' median patient age at 72, with 72% women.

In 2024, Kimalyn Dumas wrote 3,686 Medicare Part D claims for 829 patients. 88% of them were for generic drugs. CMS names the drug for 2,993 of them, across 72 drugs with 11 or more claims each, at $93,340 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Kimalyn Dumas for performance year 2024, reported as part of a group. Kimalyn Dumas accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 158 general payments to Kimalyn Dumas from 21 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Sumitomo Pharma America, Inc. paid the most, $349.